Advertisement

Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms

The results of this retrospective study of 100 patients with myeloproliferative neoplasms treated with interferon-alpha show that the IL28B genotype may affect treatment outcome.

 European Journal of Haematology